SCN5A
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
- The correct title of this article is NaV1.5. It features superscript or subscript characters that are substituted or omitted because of technical limitations.
| Sodium channel, voltage-gated, type V, alpha subunit
| ||||||||||||||
| | ||||||||||||||
| PDB rendering based on 1byy. | ||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | SCN5A; HB1; HB2; CDCD2; CMD1E; CMPD2; HH1; IVF; LQT3; Nav1.5; SSS1 | |||||||||||||
| External IDs | OMIM: 600163 MGI: 98251 Homologene: 22738 | |||||||||||||
| ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 6331 | 20271 | ||||||||||||
| Ensembl | na | ENSMUSG00000032511 | ||||||||||||
| Refseq | XM_001131636 (mRNA) XP_001131636 (protein) | NM_021544 (mRNA) NP_067519 (protein) | ||||||||||||
| Location | na | Chr 9: 119.33 - 119.43 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
|
WikiDoc Resources for SCN5A | |
|
Articles | |
|---|---|
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on SCN5A at Clinical Trials.gov Clinical Trials on SCN5A at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on SCN5A
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Directions to Hospitals Treating SCN5A Risk calculators and risk factors for SCN5A
| |
|
Healthcare Provider Resources | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [4] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
The Nav1.5 sodium ion channel protein is encoded by the SCN5A gene. Mutations in the gene are associated with long QT syndrome type 3 (LQT3), Brugada syndrome, and idiopathic ventricular fibrillation.
The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. The encoded protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene are a cause of long QT syndrome type 3 (LQT3), an autosomal dominant cardiac disease. Alternative splicing results in two transcript variants encoding separate isoforms which differ by a single amino acid. Mutation nomenclature has been assigned with respect to the longer isoform.[1]
References
Further reading
- Viswanathan PC, Balser JR (2004). "Inherited sodium channelopathies: a continuum of channel dysfunction.". Trends Cardiovasc. Med. 14 (1): 28-35. PMID 14720472.
- Catterall WA, Goldin AL, Waxman SG (2006). "International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.". Pharmacol. Rev. 57 (4): 397-409. doi:10.1124/pr.57.4.4. PMID 16382098.
- Wolf CM, Berul CI (2006). "Inherited conduction system abnormalities--one group of diseases, many genes.". J. Cardiovasc. Electrophysiol. 17 (4): 446-55. doi:10.1111/j.1540-8167.2006.00427.x. PMID 16643374.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

